Shah Prem S 4

Accession 0001127602-24-028487

CIK 0000064803other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 5:14 PM ET

Size

20.6 KB

Accession

0001127602-24-028487

Form 4

Period: 2024-11-30

EVP and Group President

Transactions

Award
Premium Stock Option
2024-11-30$71.82/sh+746,268$53,596,968→ 746,268 total
Exercise: $71.82From: 2025-11-30Exp: 2031-11-30→ Common Stock (746,268 underlying)

Holdings

ESOP Common Stock
4,968.799
Phantom Stock Credits
Exercise: $1.00→ Common Stock (39,585.66 underlying)
39,585.66
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (846 underlying)
846
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (41,580 underlying)
41,580
Common Stock
42,343.677
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (9,469 underlying)
9,469
Stock Option
Exercise: $75.24From: 2021-08-31Exp: 2028-08-31→ Common Stock (26,580 underlying)
26,580
Stock Unit (deferred)
3,468.315
Stock Option
Exercise: $79.56From: 2025-04-01Exp: 2034-04-01→ Common Stock (62,695 underlying)
62,695
Common Stock (Restricted)
37,057
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (28,596 underlying)
28,596
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (28,723 underlying)
28,723
Stock Option
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (89,073 underlying)
89,073

Footnotes (12)

[F1]Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
[F10]Option became exercisable in four equal annual installments, commencing 4/1/2024.
[F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2025.
[F12]Option becomes exercisable in three equal annual installments, commencing 11/30/2025.
[F2]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
[F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
[F4]Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
[F5]Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
[F6]Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
[F7]Option became exercisable in three equal installments, commencing on 8/31/2021.
[F8]Option became exercisable in three equal installments commencing 04/01/2022.
[F9]Option became exercisable in four equal installments, commencing 4/1/2023.

Documents

1 file

CVS HEALTH Corp

CIK 0000064803

Entity typeother